LB

Lilly Bussmann

Head of Strategic Capital at Oxford Science Enterprises

Greater Oxford Area

Investor
VC

Invests in

Stages:

Series A
Seed

Sectors:

BioTech

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Lilly

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

Oxford Science Enterprises

2021

  • Head of Strategic Capital

    2021

    Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational companies via its unique partnership with Oxford University, the world’s #1 research university. From company formation, seed to Series C+. OSE's portfolio covers deep tech, health tech and biotech. Past investments include: Base Genomics (Exact Sciences) Yasa Motors (Mercedes) LatentLogic (Waymo) PepGen (Nasdaq) Barinthus (Nasdaq) Semantic Technologies (Samsung)

RT Partners

2020 - 2021

  • Partner

    2020 - 2021

    www.rtpartners.co Oxford Nanopore (LON:ONT) E-Therapeutics (LON:ETX) CoMind

Oxford Sciences Innovation

2015 - 2019

  • Investment Principal

    2015 - 2019

    www.oxfordsciencesinnovation.com

LP
Lansdowne Partners

2015 - 2015

  • Placement

    2015 - 2015

    www.lansdownepartners.com

MV
Mosaic Ventures

2014 - 2015

  • Research Analyst

    2014 - 2015

    www.mosaicventures.com

MS
Morgan Stanley

2014 - 2014

  • Investment Banking Trainee

    2014 - 2014